Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for BCYC

Stock NameBicycle Therapeutics Ltd
TickerBCYC(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS0887861088

Show aggregate BCYC holdings

News associated with BCYC

Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Average Recommendation of “Moderate Buy” from Analysts
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten ratings firms that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average […] - 2025-07-29 02:14:55
Principal Financial Group Inc. Grows Stake in Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC)
Principal Financial Group Inc. lifted its holdings in Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Free Report) by 55.3% in the first quarter, Holdings Channel reports. The firm owned 631,260 shares of the company’s stock after buying an additional 224,790 shares during the period. Principal Financial Group Inc.’s holdings in Bicycle Therapeutics were worth $5,359,000 […] - 2025-07-17 04:35:03
Analyzing Bicycle Therapeutics (NASDAQ:BCYC) & Galecto (NASDAQ:GLTO)
Galecto (NASDAQ:GLTO – Get Free Report) and Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Profitability This table compares Galecto and Bicycle Therapeutics’ […] - 2025-07-15 06:24:40
Kevin Lee Sells 3,193 Shares of Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Stock
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Get Free Report) CEO Kevin Lee sold 3,193 shares of the company’s stock in a transaction dated Thursday, July 3rd. The shares were sold at an average price of $7.44, for a total transaction of $23,755.92. Following the transaction, the chief executive officer owned 480,804 shares in the […] - 2025-07-09 07:17:05
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives $25.00 Consensus PT from Analysts
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC – Get Free Report) has received an average recommendation of “Moderate Buy” from the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average […] - 2025-07-07 02:32:44
Bicycle Therapeutics plc (NASDAQ:BCYC) Stock Holdings Raised by Harbor Capital Advisors Inc.
Harbor Capital Advisors Inc. raised its stake in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 12.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 148,129 shares of the company’s stock after purchasing an additional 16,624 shares during the period. Harbor Capital Advisors Inc.’s holdings in Bicycle […] - 2025-06-13 05:18:56
Bicycle Therapeutics plc (NASDAQ:BCYC) Receives $25.00 Consensus Price Target from Analysts
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […] - 2025-06-12 02:29:00
Deutsche Bank AG Sells 1,653 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC)
Deutsche Bank AG cut its stake in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 20.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,417 shares of the company’s stock after selling 1,653 shares during the period. Deutsche Bank […] - 2025-06-04 04:54:43
Bicycle Therapeutics plc (NASDAQ:BCYC) Given Average Rating of “Moderate Buy” by Analysts
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price objective […] - 2025-05-15 02:52:49
Legal & General Group Plc Decreases Stake in Bicycle Therapeutics plc (NASDAQ:BCYC)
Legal & General Group Plc lessened its position in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 41.8% during the fourth quarter, Holdings Channel.com reports. The fund owned 139,075 shares of the company’s stock after selling 99,741 shares during the period. Legal & General Group Plc’s holdings in Bicycle Therapeutics were worth $1,947,000 at the […] - 2025-04-25 05:13:07
Renaissance Technologies LLC Decreases Position in Bicycle Therapeutics plc (NASDAQ:BCYC)
Renaissance Technologies LLC cut its stake in shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 1.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 269,500 shares of the company’s stock after selling 3,100 shares during the quarter. Renaissance Technologies LLC’s holdings […] - 2025-04-23 05:27:02
Bicycle Therapeutics plc (NASDAQ:BCYC) Receives $29.14 Consensus PT from Brokerages
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year price […] - 2025-04-23 02:30:48
Needham & Company LLC Reaffirms “Buy” Rating for Bicycle Therapeutics (NASDAQ:BCYC)
Needham & Company LLC reiterated their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a $30.00 price objective on the stock. BCYC has been the subject of several other reports. Stephens reissued an “equal weight” rating and […] - 2025-03-12 04:58:43

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) BCYC holdings

DateNumber of BCYC Shares HeldBase Market Value of BCYC SharesLocal Market Value of BCYC SharesChange in BCYC Shares HeldChange in BCYC Base ValueCurrent Price per BCYC Share HeldPrevious Price per BCYC Share Held
2025-11-11 (Tuesday)30,460USD 208,042BCYC holding increased by 7615USD 208,0420USD 7,615 USD 6.83001 USD 6.58001
2025-11-10 (Monday)30,460BCYC holding increased by 80USD 200,427BCYC holding increased by 4780USD 200,42780USD 4,780 USD 6.58001 USD 6.43999
2025-11-07 (Friday)30,380USD 195,647BCYC holding decreased by -2127USD 195,6470USD -2,127 USD 6.43999 USD 6.51001
2025-11-06 (Thursday)30,380BCYC holding increased by 80USD 197,774BCYC holding increased by 10823USD 197,77480USD 10,823 USD 6.51001 USD 6.17
2025-11-05 (Wednesday)30,300USD 186,951BCYC holding decreased by -21210USD 186,9510USD -21,210 USD 6.17 USD 6.87
2025-11-04 (Tuesday)30,300BCYC holding increased by 80USD 208,161BCYC holding decreased by -11236USD 208,16180USD -11,236 USD 6.87 USD 7.25999
2025-11-03 (Monday)30,220USD 219,397BCYC holding decreased by -24478USD 219,3970USD -24,478 USD 7.25999 USD 8.06999
2025-10-31 (Friday)30,220USD 243,875BCYC holding decreased by -20852USD 243,8750USD -20,852 USD 8.06999 USD 8.75999
2025-10-30 (Thursday)30,220BCYC holding increased by 400USD 264,727BCYC holding increased by 20799USD 264,727400USD 20,799 USD 8.75999 USD 8.18001
2025-10-29 (Wednesday)29,820BCYC holding increased by 160USD 243,928BCYC holding increased by 123USD 243,928160USD 123 USD 8.18001 USD 8.21999
2025-10-28 (Tuesday)29,660USD 243,805BCYC holding increased by 2966USD 243,8050USD 2,966 USD 8.21999 USD 8.11999
2025-10-27 (Monday)29,660USD 240,839BCYC holding increased by 7118USD 240,8390USD 7,118 USD 8.11999 USD 7.88001
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BCYC by Blackrock for IE00BYXG2H39

Show aggregate share trades of BCYC

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY806.6306.340 6.369USD 510 11.15
2025-11-06BUY806.6006.230 6.267USD 501 11.20
2025-11-04BUY807.3356.850 6.898USD 552 11.25
2025-10-30BUY4009.0807.990 8.099USD 3,240 11.30
2025-10-29BUY1608.1808.750 8.693USD 1,391 11.32
2025-10-22SELL-3167.8808.420 8.366USD -2,644 11.41 Profit of 961 on sale
2025-10-20BUY1588.1608.390 8.367USD 1,322 11.44
2025-10-17BUY3948.1708.730 8.674USD 3,418 11.46
2025-10-15BUY6248.3908.500 8.489USD 5,297 11.48
2025-10-03BUY5608.3708.680 8.649USD 4,843 11.51
2025-10-02BUY808.5308.690 8.674USD 694 11.53
2025-09-30BUY1627.7407.830 7.821USD 1,267 11.57
2025-09-26BUY1627.4007.530 7.517USD 1,218 11.62
2025-09-25BUY1627.5407.780 7.756USD 1,256 11.64
2025-09-18BUY817.1607.230 7.223USD 585 11.69
2025-09-17BUY2436.9207.210 7.181USD 1,745 11.72
2025-08-20SELL-3207.0307.250 7.228USD -2,313 11.83 Profit of 1,472 on sale
2025-07-30BUY3168.5108.880 8.843USD 2,794 11.98
2025-07-17SELL-1588.0408.180 8.166USD -1,290 12.19 Profit of 636 on sale
2025-07-11SELL-6408.0008.120 8.108USD -5,189 12.31 Profit of 2,689 on sale
2025-07-07BUY2407.1707.330 7.314USD 1,755 12.44
2025-07-02BUY4,4007.4407.737 7.707USD 33,912 12.51
2025-06-11BUY1608.7609.360 9.300USD 1,488 12.78
2025-06-10BUY1608.6408.960 8.928USD 1,428 12.81
2025-06-04SELL-808.4608.460 8.460USD -677 12.95 Profit of 359 on sale
2025-04-23BUY808.6709.520 9.435USD 755 14.36
2025-04-10SELL-6406.5306.815 6.787USD -4,343 15.06 Profit of 5,296 on sale
2025-04-08SELL-806.3807.280 7.190USD -575 15.26 Profit of 645 on sale
2025-04-07SELL-806.7507.085 7.052USD -564 15.35 Profit of 664 on sale
2025-04-04SELL-4056.8907.410 7.358USD -2,980 15.45 Profit of 3,279 on sale
2025-04-01BUY2,9797.8508.420 8.363USD 24,913 15.63
2025-03-31SELL-2168.4908.900 8.859USD -1,914 15.72 Profit of 1,482 on sale
2025-03-14SELL-1,1529.69010.320 10.257USD -11,816 16.72 Profit of 7,442 on sale
2025-03-07SELL-14410.23010.890 10.824USD -1,559 17.22 Profit of 921 on sale
2025-03-04SELL-7210.14010.670 10.617USD -764 17.55 Profit of 499 on sale
2025-02-25BUY14411.10011.480 11.442USD 1,648 18.11
2025-02-19SELL-7112.27012.397 12.384USD -879 18.58 Profit of 440 on sale
2025-02-13BUY21312.49012.660 12.643USD 2,693 19.07
2025-02-12BUY7112.32012.450 12.437USD 883 19.21
2025-02-11BUY28411.64011.870 11.847USD 3,365 19.37
2024-12-30BUY1,28614.13014.875 14.801USD 19,033 22.26
2024-11-18SELL-96020.46022.180 22.008USD -21,128 24.43 Profit of 2,324 on sale
2024-11-08SELL-6424.96025.280 25.248USD -1,616 24.46 Loss of -50 on sale
2024-10-21SELL-6426.70027.255 27.199USD -1,741 0.00 Loss of -1,741 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BCYC

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1926,387087,23830.2%
2025-09-1816,3190141,60911.5%
2025-09-1712,243069,26617.7%
2025-09-1613,3720117,49111.4%
2025-09-1525,73910073,98534.8%
2025-09-1229,5200155,86118.9%
2025-09-1144,0920156,84328.1%
2025-09-1036,245096,66037.5%
2025-09-0916,517080,85620.4%
2025-09-0826,75215074,30436.0%
2025-09-058,223054,95015.0%
2025-09-0423,5330100,97123.3%
2025-09-039,971056,31617.7%
2025-09-0215,920062,93725.3%
2025-08-2953,1250144,35036.8%
2025-08-2810,028051,17419.6%
2025-08-2722,088062,53735.3%
2025-08-2619,969062,72631.8%
2025-08-2522,466080,68227.8%
2025-08-2218,441077,09223.9%
2025-08-216,031067,7618.9%
2025-08-2014,315063,38222.6%
2025-08-1924,38125467,90135.9%
2025-08-1847,1600118,00140.0%
2025-08-1524,405078,26231.2%
2025-08-1436,6800202,16818.1%
2025-08-1374,00131259,61728.5%
2025-08-1226,8960102,38226.3%
2025-08-1115,761065,78324.0%
2025-08-0866,9160127,61652.4%
2025-08-0719,839044,35244.7%
2025-08-0621,165071,99129.4%
2025-08-0520,479071,05628.8%
2025-08-0415,909051,91230.6%
2025-08-0114,179038,07337.2%
2025-07-3121,8550110,10819.8%
2025-07-3018,7551968,70827.3%
2025-07-2928,399145209,63813.5%
2025-07-2829,378078,99637.2%
2025-07-2520,752073,81828.1%
2025-07-2417,151073,85023.2%
2025-07-2339,2660137,33028.6%
2025-07-2222,7210193,78911.7%
2025-07-2128,8370135,60421.3%
2025-07-1845,3930263,43517.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.